Cancer Prostate Clinical Trial
Official title:
Study to Assess Efficacy and Safety of Zoledronic Acid and the Value of Markers of Bone Resorption in the Prediction of Bone Metastases and Cancer Treatment-induced Bone Loss (CTIBL) in Patients With Prostate Cancer on Hormone Therapy
The objective of the study is to investigate whether blood markers can be used to predict the development of bone metastases and to assess the efficacy and safety of zoledronic acid in cancer treatment induced bone loss.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06152419 -
Patient Education Videos to Improve Patients' Experience During Radiotherapy Treatment: a National Project
|
N/A | |
Active, not recruiting |
NCT05410002 -
Diet Effect on Cancer Treatment Outcome
|
Phase 1 | |
Completed |
NCT04836221 -
Comorbidities And Reducing inEquitieS
|
N/A | |
Terminated |
NCT03157856 -
Assessment of a New Fluorescence Imaging Technique Using Biopsies From Prostate Resection
|
||
Not yet recruiting |
NCT06035731 -
Evaluation of the Medical Service by Socio-aesthetics in Oncology
|
N/A | |
Not yet recruiting |
NCT05154474 -
Assessment of Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic Malignancy
|
||
Active, not recruiting |
NCT06359717 -
Prospective Validation of PSMA-RADS
|
||
Recruiting |
NCT03452774 -
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
|
||
Completed |
NCT04074460 -
Volatile Anaesthesia and Perioperative Outcomes Related to Cancer Feasibility Study
|
Phase 4 | |
Completed |
NCT03866785 -
Physical Activity Experiment on Male Prostate Cancer Patients
|
N/A |